These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 11850637)
1. Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex. Hart PJ; Deep S; Taylor AB; Shu Z; Hinck CS; Hinck AP Nat Struct Biol; 2002 Mar; 9(3):203-8. PubMed ID: 11850637 [TBL] [Abstract][Full Text] [Related]
2. Solution structure and backbone dynamics of the TGFbeta type II receptor extracellular domain. Deep S; Walker KP; Shu Z; Hinck AP Biochemistry; 2003 Sep; 42(34):10126-39. PubMed ID: 12939140 [TBL] [Abstract][Full Text] [Related]
3. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling. Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441 [TBL] [Abstract][Full Text] [Related]
4. Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding. Groppe J; Hinck CS; Samavarchi-Tehrani P; Zubieta C; Schuermann JP; Taylor AB; Schwarz PM; Wrana JL; Hinck AP Mol Cell; 2008 Feb; 29(2):157-68. PubMed ID: 18243111 [TBL] [Abstract][Full Text] [Related]
5. The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding. Thompson TB; Lerch TF; Cook RW; Woodruff TK; Jardetzky TS Dev Cell; 2005 Oct; 9(4):535-43. PubMed ID: 16198295 [TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta receptor expression on human skin fibroblasts: dimeric complex formation of type I and type II receptors and identification of glycosyl phosphatidylinositol-anchored transforming growth factor-beta binding proteins. Tam BY; Philip A J Cell Physiol; 1998 Sep; 176(3):553-64. PubMed ID: 9699508 [TBL] [Abstract][Full Text] [Related]
8. Assembly of TbetaRI:TbetaRII:TGFbeta ternary complex in vitro with receptor extracellular domains is cooperative and isoform-dependent. Zúñiga JE; Groppe JC; Cui Y; Hinck CS; Contreras-Shannon V; Pakhomova ON; Yang J; Tang Y; Mendoza V; López-Casillas F; Sun L; Hinck AP J Mol Biol; 2005 Dec; 354(5):1052-68. PubMed ID: 16289576 [TBL] [Abstract][Full Text] [Related]
9. Growth factor-binding sequence in human alpha2-macroglobulin targets the receptor-binding site in transforming growth factor-beta. Arandjelovic S; Freed TA; Gonias SL Biochemistry; 2003 May; 42(20):6121-7. PubMed ID: 12755614 [TBL] [Abstract][Full Text] [Related]
10. Expression of recombinant extracellular domain of the type II transforming growth factor-beta receptor: utilization in a modified enzyme-linked immunoabsorbent assay to screen TGF-beta agonists and antagonists. Fahey MS; Dawbarn D; Allen SJ; Paterson IC; Prime SS Anal Biochem; 2001 Mar; 290(2):272-6. PubMed ID: 11237329 [TBL] [Abstract][Full Text] [Related]
11. The novel type I serine-threonine kinase receptor Alk8 binds TGF-beta in the presence of TGF-betaRII. de Caestecker MP; Bottomley M; Bhattacharyya S; Payne TL; Roberts AB; Yelick PC Biochem Biophys Res Commun; 2002 May; 293(5):1556-65. PubMed ID: 12054694 [TBL] [Abstract][Full Text] [Related]
12. Ligand-induced dimerization of the extracellular domain of the TGF-beta receptor type II. Letourneur O; Goetschy JF; Horisberger M; Grütter MG Biochem Biophys Res Commun; 1996 Jul; 224(3):709-16. PubMed ID: 8713111 [TBL] [Abstract][Full Text] [Related]
13. TGF-beta receptors: structure and function. Lin HY; Moustakas A Cell Mol Biol (Noisy-le-grand); 1994 May; 40(3):337-49. PubMed ID: 7920178 [TBL] [Abstract][Full Text] [Related]
14. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
15. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding. Mace PD; Cutfield JF; Cutfield SM Biochem Biophys Res Commun; 2006 Dec; 351(4):831-8. PubMed ID: 17094948 [TBL] [Abstract][Full Text] [Related]
16. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes. Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420 [TBL] [Abstract][Full Text] [Related]
17. Scanning-deletion analysis of the extracellular domain of the TGF-beta receptor type II. Pepin MC; Beauchemin M; Plamondon J; O'Connor-McCourt MD Biochem Biophys Res Commun; 1996 Mar; 220(2):289-93. PubMed ID: 8645298 [TBL] [Abstract][Full Text] [Related]
18. Localization of recognition site between transforming growth factor-beta1 (TGF-beta1) and TGF beta receptor type II: possible implications in breast cancer. Ivanović V; Demajo M; Todorović-Raković N; Nikolić-Vukosavljević D; Nesković-Konstantinović Z; Krtolica K; Veljković V; Prljić J; Dimitrijević B Med Hypotheses; 2004; 62(5):727-32. PubMed ID: 15082097 [TBL] [Abstract][Full Text] [Related]
19. Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily. Radaev S; Zou Z; Huang T; Lafer EM; Hinck AP; Sun PD J Biol Chem; 2010 May; 285(19):14806-14. PubMed ID: 20207738 [TBL] [Abstract][Full Text] [Related]
20. A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily. Keah HH; Hearn MT J Mol Recognit; 2005; 18(5):385-403. PubMed ID: 15948132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]